Day 3

Recordings from the conference:

Concerns for nano and effect on nerves, brain pathologies of different nanomaterials (TiO2, SWCNT, C60, Cu-NPs), and effects on brain biochemistry (Richard Handy)

Effects of nanomaterials on animal behavior - are the defects all neurological? (David Boyle)

Invited speaker: Nanomaterial properties in complement activation: lessons from nanomedicine (Moein Moghimi)

A proteomic approach to detect protein modification on cellular proteins after nanoparticle treatment (Andrea Haase)

Double Walled Carbon Nanotubes induce IL-1β secretion in human monocytes through the Nlrp3 Inflammasome activation (Etienne Meunier)

Effects of engineered nanoparticles on the inflammatory response in a human monocyte-based in vitro model (Linda Stöhr)

The Immunosafety Focus Group: do we really need it? (Diana Boraschi)

Toxicity and tissue Distribution of Inhaled Micro- and Nano-sized Cerium Oxide Particles in Rats: Results from a 28-day Exposure Study (Flemming Cassee)

Biological responses induced in bronchial epithelial cells by carbon black and titanium dioxide nanoparticles: similar outcomes but distinct molecular pathways (Sonja Boland)

Effects of silver nanoparticles in primary mixed neural cultures: Oxidative stress and interference with calcium signalling (Andrea Haase)

Bioavailability and toxicity profiles of silver nanoparticles in rats after twenty-eight-day oral exposure (Meike van der Zande)

Keynote: Death, damage and immunity (Polly Matzinger)

Keynote 1: Toxicology testing strategies for Nanomaterials (Robert Landsiedel)

Keynote 2: Review of Nanomaterials Under the Toxics Substances Control Act (Maria Doa)

Nano -TAB: Standardizing a File Format to Enable Nanotechnology Data Sharing (Stacey Harper)

Therapeutic nanoparticles: an overview of their toxicity assessment in patents (Catherine Schütz)

Closing session : Awards and closing notes (Flemming Cassee)